Skip to main content

New Gene Therapy Offers Hope for Chronic Pain Relief

Published on June 22, 2026, 5:08 p.m.
New Gene Therapy Offers Hope for Chronic Pain Relief

Topic: Health

Scientists have developed a gene therapy that targets pain-processing areas in the brain without the risks of addiction. This new approach could offer relief to millions living with chronic pain.

This new gene therapy has been identified as a potential solution for people living with chronic pain. The therapy works by directly targeting the brain circuits responsible for processing pain signals, reducing the volume of pain without affecting other brain functions.

The research was conducted by scientists from the University of Pennsylvania Perelman School of Medicine and School of Nursing, along with collaborators from Carnegie Mellon University and Stanford University. The team used an artificial intelligence-powered system to monitor natural behavior, estimate pain levels, and determine how much treatment is needed.

The therapy introduces a brain-specific 'off switch' for pain, reducing pain over a sustained period without interfering with normal sensations or activating reward pathways associated with addiction. This represents the world's first CNS-targeted gene therapy for pain, and a concrete blueprint for non-addictive, circuit-specific pain medicine.

Why It Matters

This new approach could help reduce the burden of chronic pain on individuals and society. Chronic pain affects about 50 million Americans and leads to significant medical expenses and lost productivity.

Key Facts

  • The gene therapy targets pain-processing areas in the brain without the risks of addiction.
  • The research was conducted by scientists from the University of Pennsylvania Perelman School of Medicine and School of Nursing, along with collaborators from Carnegie Mellon University and Stanford University.
  • The therapy introduces a brain-specific 'off switch' for pain, reducing pain over a sustained period without interfering with normal sensations or activating reward pathways associated with addiction.
  • Chronic pain affects about 50 million Americans and leads to significant medical expenses and lost productivity.
  • The research reflects more than six years of work supported by a National Institutes of Health New Innovator Award.

Key Terms

Gene therapy
A treatment that uses genes to cure or treat a disease

Implications

This new approach could help reduce the burden of chronic pain on individuals and society. Chronic pain affects about 50 million Americans and leads to significant medical expenses and lost productivity.


Source: https://www.sciencedaily.com/releases/2026/03/260328043558.htm

Journal Reference:

  1. Corinna S. Oswell, Sophie A. Rogers, Justin G. James, Nora M. McCall, Alex I. Hsu, Gregory J. Salimando, Malaika Mahmood, Lisa M. Wooldridge, Meghan Wachira, Adrienne Y. Jo, Raquel Adaia Sandoval Ortega, Jessica A. Wojick, Katherine Beattie, Sofia A. Farinas, Samar N. Chehimi, Amrith Rodrigues, Jacqueline W. K. Wu, Lindsay L. Ejoh, Blake A. Kimmey, Emily Lo, Ghalia Azouz, Jose J. Vasquez, Matthew R. Banghart, Kevin T. Beier, Kate Townsend Creasy, Richard C. Crist, Charu Ramakrishnan, Benjamin C. Reiner, Karl Deisseroth, Eric A. Yttri, Gregory Corder. Mimicking opioid analgesia in cortical pain circuits. Nature, 2026; 649 (8098): 938 DOI: 10.1038/s41586-025-09908-w

Leave a Comment

Name
Email
Body
... ...

Get Exclusive Insights

with Every Issue

JoinShalyamNewsletter

Stay ahead in education, research, and innovation—straight to your inbox.